Home Pharmaceuticals Anti-obesity Drugs Market

Anti-obesity Drugs Market Size, Share & Trends Analysis Report By Drug Class (GLP-1 Receptor Agonists, Dual GIP/GLP-1 Agonists, Triple or Multi-Receptor Agonists, Centrally Acting Sympathomimetics, Peripherally Acting Lipase Inhibitors), By Type (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, E-commerce) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 28, 2026 | Author: Dhanashri B | Format: | Report Code: SRPH58221DR | Pages: 210

Market Segmentation

  1. Anti-obesity Drugs Market, By Drug Class (2022-2034)
    1. GLP-1 Receptor Agonists
    2. Dual GIP/GLP-1 Agonists
    3. Triple or Multi-Receptor Agonists
    4. Centrally Acting Sympathomimetics
    5. Peripherally Acting Lipase Inhibitors
  2. Anti-obesity Drugs Market, By Type (2022-2034)
    1. Prescription Drugs
    2. OTC Drugs
  3. Anti-obesity Drugs Market, By Distribution Channel (2022-2034)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. E-commerce
    1. North America
      1. North America Anti-obesity Drugs Market, By Drug Class
        1. GLP-1 Receptor Agonists
          1. Dual GIP/GLP-1 Agonists
            1. Triple or Multi-Receptor Agonists
              1. Centrally Acting Sympathomimetics
                1. Peripherally Acting Lipase Inhibitors
                2. North America Anti-obesity Drugs Market, By Type
                  1. Prescription Drugs
                    1. OTC Drugs
                    2. North America Anti-obesity Drugs Market, By Distribution Channel
                      1. Hospital Pharmacies
                        1. Drug Stores & Retail Pharmacies
                          1. E-commerce
                          2. U.S.
                            1. U.S. Anti-obesity Drugs Market, By Drug Class
                              1. GLP-1 Receptor Agonists
                                1. Dual GIP/GLP-1 Agonists
                                  1. Triple or Multi-Receptor Agonists
                                    1. Centrally Acting Sympathomimetics
                                      1. Peripherally Acting Lipase Inhibitors
                                      2. U.S. Anti-obesity Drugs Market, By Type
                                        1. Prescription Drugs
                                          1. OTC Drugs
                                          2. U.S. Anti-obesity Drugs Market, By Distribution Channel
                                            1. Hospital Pharmacies
                                              1. Drug Stores & Retail Pharmacies
                                                1. E-commerce
                                              2. Canada
                                            2. Europe
                                              1. Europe Anti-obesity Drugs Market, By Drug Class
                                                1. GLP-1 Receptor Agonists
                                                  1. Dual GIP/GLP-1 Agonists
                                                    1. Triple or Multi-Receptor Agonists
                                                      1. Centrally Acting Sympathomimetics
                                                        1. Peripherally Acting Lipase Inhibitors
                                                        2. Europe Anti-obesity Drugs Market, By Type
                                                          1. Prescription Drugs
                                                            1. OTC Drugs
                                                            2. Europe Anti-obesity Drugs Market, By Distribution Channel
                                                              1. Hospital Pharmacies
                                                                1. Drug Stores & Retail Pharmacies
                                                                  1. E-commerce
                                                                  2. U.K.
                                                                    1. U.K. Anti-obesity Drugs Market, By Drug Class
                                                                      1. GLP-1 Receptor Agonists
                                                                        1. Dual GIP/GLP-1 Agonists
                                                                          1. Triple or Multi-Receptor Agonists
                                                                            1. Centrally Acting Sympathomimetics
                                                                              1. Peripherally Acting Lipase Inhibitors
                                                                              2. U.K. Anti-obesity Drugs Market, By Type
                                                                                1. Prescription Drugs
                                                                                  1. OTC Drugs
                                                                                  2. U.K. Anti-obesity Drugs Market, By Distribution Channel
                                                                                    1. Hospital Pharmacies
                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                        1. E-commerce
                                                                                      2. Germany
                                                                                      3. France
                                                                                      4. Spain
                                                                                      5. Italy
                                                                                      6. Russia
                                                                                      7. Nordic
                                                                                      8. Benelux
                                                                                      9. Rest of Europe
                                                                                    2. APAC
                                                                                      1. APAC Anti-obesity Drugs Market, By Drug Class
                                                                                        1. GLP-1 Receptor Agonists
                                                                                          1. Dual GIP/GLP-1 Agonists
                                                                                            1. Triple or Multi-Receptor Agonists
                                                                                              1. Centrally Acting Sympathomimetics
                                                                                                1. Peripherally Acting Lipase Inhibitors
                                                                                                2. APAC Anti-obesity Drugs Market, By Type
                                                                                                  1. Prescription Drugs
                                                                                                    1. OTC Drugs
                                                                                                    2. APAC Anti-obesity Drugs Market, By Distribution Channel
                                                                                                      1. Hospital Pharmacies
                                                                                                        1. Drug Stores & Retail Pharmacies
                                                                                                          1. E-commerce
                                                                                                          2. China
                                                                                                            1. China Anti-obesity Drugs Market, By Drug Class
                                                                                                              1. GLP-1 Receptor Agonists
                                                                                                                1. Dual GIP/GLP-1 Agonists
                                                                                                                  1. Triple or Multi-Receptor Agonists
                                                                                                                    1. Centrally Acting Sympathomimetics
                                                                                                                      1. Peripherally Acting Lipase Inhibitors
                                                                                                                      2. China Anti-obesity Drugs Market, By Type
                                                                                                                        1. Prescription Drugs
                                                                                                                          1. OTC Drugs
                                                                                                                          2. China Anti-obesity Drugs Market, By Distribution Channel
                                                                                                                            1. Hospital Pharmacies
                                                                                                                              1. Drug Stores & Retail Pharmacies
                                                                                                                                1. E-commerce
                                                                                                                              2. Korea
                                                                                                                              3. Japan
                                                                                                                              4. India
                                                                                                                              5. Australia
                                                                                                                              6. Taiwan
                                                                                                                              7. South East Asia
                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                            2. Middle East and Africa
                                                                                                                              1. Middle East and Africa Anti-obesity Drugs Market, By Drug Class
                                                                                                                                1. GLP-1 Receptor Agonists
                                                                                                                                  1. Dual GIP/GLP-1 Agonists
                                                                                                                                    1. Triple or Multi-Receptor Agonists
                                                                                                                                      1. Centrally Acting Sympathomimetics
                                                                                                                                        1. Peripherally Acting Lipase Inhibitors
                                                                                                                                        2. Middle East and Africa Anti-obesity Drugs Market, By Type
                                                                                                                                          1. Prescription Drugs
                                                                                                                                            1. OTC Drugs
                                                                                                                                            2. Middle East and Africa Anti-obesity Drugs Market, By Distribution Channel
                                                                                                                                              1. Hospital Pharmacies
                                                                                                                                                1. Drug Stores & Retail Pharmacies
                                                                                                                                                  1. E-commerce
                                                                                                                                                  2. UAE
                                                                                                                                                    1. UAE Anti-obesity Drugs Market, By Drug Class
                                                                                                                                                      1. GLP-1 Receptor Agonists
                                                                                                                                                        1. Dual GIP/GLP-1 Agonists
                                                                                                                                                          1. Triple or Multi-Receptor Agonists
                                                                                                                                                            1. Centrally Acting Sympathomimetics
                                                                                                                                                              1. Peripherally Acting Lipase Inhibitors
                                                                                                                                                              2. UAE Anti-obesity Drugs Market, By Type
                                                                                                                                                                1. Prescription Drugs
                                                                                                                                                                  1. OTC Drugs
                                                                                                                                                                  2. UAE Anti-obesity Drugs Market, By Distribution Channel
                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                                                        1. E-commerce
                                                                                                                                                                      2. Turkey
                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                      4. South Africa
                                                                                                                                                                      5. Egypt
                                                                                                                                                                      6. Nigeria
                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                    2. LATAM
                                                                                                                                                                      1. LATAM Anti-obesity Drugs Market, By Drug Class
                                                                                                                                                                        1. GLP-1 Receptor Agonists
                                                                                                                                                                          1. Dual GIP/GLP-1 Agonists
                                                                                                                                                                            1. Triple or Multi-Receptor Agonists
                                                                                                                                                                              1. Centrally Acting Sympathomimetics
                                                                                                                                                                                1. Peripherally Acting Lipase Inhibitors
                                                                                                                                                                                2. LATAM Anti-obesity Drugs Market, By Type
                                                                                                                                                                                  1. Prescription Drugs
                                                                                                                                                                                    1. OTC Drugs
                                                                                                                                                                                    2. LATAM Anti-obesity Drugs Market, By Distribution Channel
                                                                                                                                                                                      1. Hospital Pharmacies
                                                                                                                                                                                        1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                          1. E-commerce
                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                            1. Brazil Anti-obesity Drugs Market, By Drug Class
                                                                                                                                                                                              1. GLP-1 Receptor Agonists
                                                                                                                                                                                                1. Dual GIP/GLP-1 Agonists
                                                                                                                                                                                                  1. Triple or Multi-Receptor Agonists
                                                                                                                                                                                                    1. Centrally Acting Sympathomimetics
                                                                                                                                                                                                      1. Peripherally Acting Lipase Inhibitors
                                                                                                                                                                                                      2. Brazil Anti-obesity Drugs Market, By Type
                                                                                                                                                                                                        1. Prescription Drugs
                                                                                                                                                                                                          1. OTC Drugs
                                                                                                                                                                                                          2. Brazil Anti-obesity Drugs Market, By Distribution Channel
                                                                                                                                                                                                            1. Hospital Pharmacies
                                                                                                                                                                                                              1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                                1. E-commerce
                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                              6. Rest of LATAM
                                                                                                                                                                                                          Get This Report

                                                                                                                                                                                                          Download Free Sample

                                                                                                                                                                                                          Our Clients:

                                                                                                                                                                                                          LG Electronics
                                                                                                                                                                                                          AMCAD Engineering
                                                                                                                                                                                                          KOBE STEEL LTD.
                                                                                                                                                                                                          Hindustan National Glass & Industries Limited
                                                                                                                                                                                                          Voith Group
                                                                                                                                                                                                          International Paper
                                                                                                                                                                                                          Hansol Paper
                                                                                                                                                                                                          Whirlpool Corporation
                                                                                                                                                                                                          Sony
                                                                                                                                                                                                          Samsung Electronics
                                                                                                                                                                                                          Qualcomm
                                                                                                                                                                                                          Google
                                                                                                                                                                                                          Fiserv
                                                                                                                                                                                                          Veto-Pharma
                                                                                                                                                                                                          Nippon Becton Dickinson
                                                                                                                                                                                                          Merck
                                                                                                                                                                                                          Argon Medical Devices
                                                                                                                                                                                                          Abbott
                                                                                                                                                                                                          Ajinomoto
                                                                                                                                                                                                          Denon
                                                                                                                                                                                                          Doosan
                                                                                                                                                                                                          Meiji Seika Kaisha Ltd
                                                                                                                                                                                                          LG Chemicals
                                                                                                                                                                                                          LCY chemical group
                                                                                                                                                                                                          Bayer
                                                                                                                                                                                                          Airrane
                                                                                                                                                                                                          BASF
                                                                                                                                                                                                          Toyota Industries
                                                                                                                                                                                                          Nissan Motors
                                                                                                                                                                                                          Neenah
                                                                                                                                                                                                          Mitsubishi
                                                                                                                                                                                                          Hyundai Motor Company

                                                                                                                                                                                                          We are featured on:

                                                                                                                                                                                                          Straits Research
                                                                                                                                                                                                          Address:
                                                                                                                                                                                                          105, Panchshil The Golden Bell,
                                                                                                                                                                                                          Koregaon Park Annexe, Mundhwa,
                                                                                                                                                                                                          Pune, Maharashtra 411036
                                                                                                                                                                                                          Contact Us:
                                                                                                                                                                                                          +1 646 905 0080 (U.S.)
                                                                                                                                                                                                          +91 8087085354 (India)
                                                                                                                                                                                                          +44 203 695 0070 (U.K.)

                                                                                                                                                                                                          sales@straitsresearch.com

                                                                                                                                                                                                          Quick Links
                                                                                                                                                                                                          Help
                                                                                                                                                                                                          Verified. Protected. Secure.
                                                                                                                                                                                                          Duns
                                                                                                                                                                                                          DMCA.com Protection Status
                                                                                                                                                                                                          lets-encrypt
                                                                                                                                                                                                          Secure Payments:
                                                                                                                                                                                                          Secure Payments
                                                                                                                                                                                                          Follow Us:
                                                                                                                                                                                                          www.straitsresearch.com © Copyright . All rights Reserved.